 Obalon Therapeutics, Inc. NASDAQ: OBLN, a vertically integrated weight loss solutions company commercializing the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, announces that it has opened its second Company-managed retail treatment center. We are excited to have opened the second Company-managed Obalon Center for Weight LossTM, further developing our strategy to build a standardized, repeatable business using a Company-owned or managed retail treatment center model, said Bill Plovanic, President and Chief Executive Officer of Obalon. 